MYUNGMOON Pharm Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include ethical drugs (ETC), over-the-counter drugs (OTC), and indication drugs. The ethical drugs include anesthetic agent, analgesic agent, anti-epileptics, anti-depressants, anti-diabetics, anti-osteoporosis, and others. The over-the-counter drugs provide medicines for eye nutrition, colds, parasiticide, cathartic, muscle relaxant, hepatics, and others. The company was founded on September 1, 1983 and is headquartered in Hwaseong, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company